Evidence map›Paper›PMID 36578926›Full record

ArticleFrontiers in oncology2022

Case report: Multicentric Castleman disease as a manifestation of immune reconstitution inflammatory syndrome in Malawi.

Matthew S Painschab, Marriam Mponda, Tamiwe Tomoka, Coxcilly Kampani, Fred Chimzimu, Yuri Fedoriw, Satish Gopal

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Matthew S PainschabUniversity of North Carolina (UNC) Project Malawi, Lilongwe, Malawi.
Marriam MpondaUniversity of North Carolina (UNC) Project Malawi, Lilongwe, Malawi.
Tamiwe TomokaUniversity of North Carolina (UNC) Project Malawi, Lilongwe, Malawi.
Coxcilly KampaniUniversity of North Carolina (UNC) Project Malawi, Lilongwe, Malawi.
Fred ChimzimuUniversity of North Carolina (UNC) Project Malawi, Lilongwe, Malawi.
Yuri FedoriwUniversity of North Carolina (UNC) Project Malawi, Lilongwe, Malawi.
Satish GopalCenter for Global Health, National Cancer Institute, Rockville, MD, United States.
University of Malawi · MWCenter for Global Health · USUniversity of North Carolina at Chapel Hill · US

Funding

The road to recovery: An assessment of patient-reported quality of life among cancer survivors in Malawi.U54CA254564 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI OLSHAN, ANDREW · 2020 to 2024
$6.1M
Project 3U54CA190152 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAMANIA, BLOSSOM A, GOPAL, SATISH · 2014 to 2019
$4.2M
Malawi Cancer Outcomes Research Program (M-CORP)D43CA260641 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CHINULA, LAMECK, FEDORIW, YURI · 2021 to 2025
$1.3M
Safety, efficacy, and cost-effectiveness of rituximab for multicentric Castleman disease in MalawiK01TW011470 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PAINSCHAB, MATTHEW SCOTT · 2019 to 2023
$720k
FIC NIH HHS K01 TW011470FIC NIH HHS L30 TW011802NCI NIH HHS D43 CA260641NCI NIH HHS L30 CA233709NCI NIH HHS U54 CA190152NCI NIH HHS U54 CA254564
6 · The paper itself

Abstract

Introduction: Multicentric Castleman disease (MCD) is a lymphoproliferative disorder characterized by systemic inflammation, lymphadenopathy, and cytopenias. MCD caused by Kaposi sarcoma herpesvirus (MCD-KSHV) frequently arises in the context of HIV. It can be associated with immune reconstitution inflammatory syndrome (IRIS), but MCD-IRIS is rarely reported in sub-Saharan Africa (SSA) where HIV and KSHV infection are common. Case description: A 36-year-old woman in Malawi with HIV on antiretroviral therapy (ART) for nine years presented with fatigue, weight loss, and lymphadenopathy. Lymph node biopsy was consistent with HIV lymphadenitis without evident KSHV-MCD and HIV RNA was 4,244 copies/mL. She switched to second-line ART and returned four months later with worsening lymphadenopathy, fever, night sweats, weight loss, and anemia. A repeat lymph node biopsy demonstrated unequivocal KSHV-MCD features not present on the original biopsy. Her repeat HIV viral load was undetectable and she received chemotherapy with subsequent remission on continued ART for 24 months. Discussion: This is among the first reported cases of MCD-IRIS from SSA, which has implications for a region where HIV and KSHV are highly prevalent. MCD-IRIS may contribute to early mortality after ART initiation in SSA, and increased awareness alongside improved diagnostic and treatment capacity are needed.

Indexed as

africaHIVIRISKSHVmalawimulticentric castleman disease

Identifiers

PMID36578926
PMCPMC9791082
OpenAlexW4312123625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.